Main Article Content
Abstract
Background: The ABO blood group is known to affect the levels of several
coagulation factors, such as factor VIII and von Willebrand factor (vWF),
which can affect the results of coagulation time. This study aims to analyze
the relationship between ABO blood group and the coagulation parameters
Activated Partial Thromboplastin Time (APTT) and Prothrombin Time (PT).
Methods: This analytical cross-sectional study involved 45 healthy Medical
Laboratory Technology students from Muhammadiyah University of
Surabaya. Inclusion criteria were healthy volunteers; exclusion criteria
included bleeding disorders, recent transfusion, smoking, or refusal to
consent. Conducted in May 2025 at the Clinical Pathology Laboratory, data
were analyzed using one-way ANOVA. Ethical approval was obtained from
KEPK FIK Muhammadiyah University of Surabaya (No.
057/KEPK/F/V/FIK/2025). Results: The test results showed that the
distribution of APTT and PT data was normal and homogeneous. There was
a significant difference between blood groups on APTT values (p = 0.006),
but there was no significant difference on PT values (p = 0.605). Blood type
O has a higher APTT value than other blood types. Conclusion: There is a
significant relationship between ABO blood group and APTT values, but not
with PT. The difference in APTT values may be influenced by lower vWF
and factor VIII levels in blood group O. This finding is important to consider
in the interpretation of coagulation test results in clinical laboratories.
Keywords
Article Details
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
References
Do L, Favaloro E, Pasalic L. An Analysis of the Sensitivity of the Activated Partial Thromboplastin Time (APTT) Assay, as Used in a Large Laboratory Network, to Coagulation Factor Deficiencies. Am J Clin Pathol. 2022;158(1):132–41. https://doi.org/10.1093/ajcp/aqac013
Khan M, Din Z, Haq NU, Farooq S, Hasan F. Difference of Clotting Time and Bleeding Time in the ABO Blood Groups. Pakistan J Med Heal Sci. 2022;16(7):903–5. DOI: https://doi.org/10.53350/pjmhs22167903
Kaur M, Singh A, Bassi R, Kaur D. Blood group distribution and its relationship with bleeding time and clotting time. Natl J Physiol Pharm Pharmacol. 2015;5(3):253–7. doi: http://dx.doi.org/10.5455/njppp.2015.5.2609201433
Chanu LL, Singh RB, Rajkumari B, Anal SR. Bleeding Time and Clotting Time in Different Blood Groups- a Cross Sectional Study. J Evol Med Dent Sci. 2019;8(22):1813–5. https://www.jemds.com/data_pdf/rajkumar%20singh-.pdf
Okeke C, Okoro U, Babatunde A. Variations in activated partial thromboplastin time and prothrombin time in individuals of A, B, AB, and O blood groups. Iraqi J Hematol. 2018;7(2):85. https://journals.lww.com/ijhm/fulltext/2018/07020/variations_in_activated_partial_thromboplastin.7.aspx
Chen Z, Yu M. Effect of ABO Blood Groups , Age and Gender on Coagulation Assays in Patients With Acute Deep Vein Thrombosis. 2021;1–12. DOI: 10.21203/rs.3.rs-184439/v1
Salim EI, Shaaban AN, Seleem AK, Attia ZI. Impact of ABO gene polymorphism and von Willebrand factor on genetic susceptibility to acute lymphoblastic leukemia in Egyptian pediatric patients. Egypt J Med Hum Genet [Internet]. 2025; Tersedia pada: https://doi.org/10.1186/s43042-024-00633-z
Ward SE, Sullivan JMO, Donnell JSO. Review Article The relationship between ABO blood group , von Willebrand factor , and primary hemostasis. 2020;136(25):2864–74. https://doi.org/10.1182/blood.2020005843
Leeman M, Choi J, Hansson S, Storm MU, Nilsson L. Proteins and antibodies in serum, plasma, and whole blood—size characterization using asymmetrical flow field-flow fractionation (AF4). Anal Bioanal Chem. 2018;410(20):4867–73. DOI: 10.1007/s00216-018-1127-2
Zhang H, Mooney CJ, Reilly MP. ABO blood groups and cardiovascular diseases. Int J Vasc Med. 2012;2012. DOI: 10.1155/2012/641917
Liu X, Chen X, Yang J, Guo R. Association of ABO blood groups with von Willebrand factor, factor VIII and ADAMTS-13 in patients with lung cancer. Oncol Lett. 2017;14(3):3787–94. doi: 10.3892/ol.2017.6619
Chen Z, Dai X, Cao J, Tan X, Chen S, Yu M. Reference intervals for coagulation tests in adults with different ABO blood types. J Clin Lab Anal. 2022;36(3):1–9. doi: 10.1002/jcla.24269
Amania N. Frekuensi Alel Golongan Darah Sistem a-B-O Pada Populasi Suku Osing Desa Kemiren Kabupaten Banyuwangi. Bioma J Biol dan Pembelajaran Biol. 2020;5(1):11–21. DOI: https://jurnal.unmuhjember.ac.id/index.php/BIOMA/article/view/3680
Choi Q, Kim JE, Kim SY, Han KS, Kim HK. Influence of ABO type on global coagulation assay results: Effect of coagulation factor VIII. Clin Chem Lab Med. 2015;53(9):1425–32. DOI: 10.1515/cclm-2014-0909
Mitsuguro M, Okamoto A, Shironouchi Y, Sano M, Miyata S, Neki R, et al. Effects of factor VIII levels on the APTT and anti-Xa activity under a therapeutic dose of heparin. Int J Hematol. 2015;101(2):119–25. DOI: 10.1007/s12185-014-1702-z
Assagaf KK, Bodhi W, Yamlean PVY, Lippi G, Salvagno GL, Tarperi C, et al. Prothrombotic State Induced by Middle-Distance Endurance Exercise in Middle-Aged Athletes. J Ilm Farm [Internet]. 2018;5(3):253–7. DOI: 10.1055/s-0038-1667115
Rios DRA, Fernandes AP, Figueiredo RC, Guimarães DAM, Ferreira CN, Simões e Silva AC, et al. Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis. J Thromb Thrombolysis. 2012;33(4):416–21. DOI: 10.1007/s11239-012-0719-5
Höglund J, Karlsson T, Johansson T, Ek WE, Johansson Å. Characterization of the human ABO genotypes and their association to common inflammatory and cardiovascular diseases in the UK Biobank. Am J Hematol. 2021;96(11):1350–62. DOI: 10.1002/ajh.26307